ProfileGDS4718 / 236906_x_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 54% 50% 55% 52% 51% 63% 60% 55% 51% 52% 56% 50% 65% 64% 65% 53% 57% 61% 59% 52% 54% 56% 48% 50% 54% 57% 53% 63% 54% 74% 63% 61% 57% 52% 63% 67% 60% 56% 51% 54% 53% 62% 57% 60% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.7699154
GSM549102patient 115, normal, homogenized [OPG study]5.5263150
GSM549104patient 119, normal, homogenized [OPG study]5.8048155
GSM549108patient 138, normal, homogenized [OPG study]5.6724652
GSM549119patient 077, normal, homogenized [OPG study]5.6028251
GSM549133patient 032, cancer, homogenized [OPG study]6.3226463
GSM549139patient 042, cancer, homogenized [OPG study]6.1135260
GSM549099patient 107, normal, homogenized [OPG study]5.810655
GSM549109patient 139, normal, homogenized [OPG study]5.5915451
GSM549110patient 046, normal, homogenized [OPG study]5.6511552
GSM549114patient 063, normal, homogenized [OPG study]5.8094656
GSM549122patient 082, normal, homogenized [OPG study]5.4910850
GSM549134patient 033, cancer, homogenized [OPG study]6.4537665
GSM549136patient 036, cancer, homogenized [OPG study]6.3838464
GSM549140patient 044, cancer, homogenized [OPG study]6.4607265
GSM549111patient 047, normal, homogenized [OPG study]5.6713353
GSM549113patient 057, normal, homogenized [OPG study]5.8651557
GSM549132patient 031, cancer, homogenized [OPG study]6.174661
GSM549137patient 038, cancer, homogenized [OPG study]6.0435359
GSM549142patient 047, cancer, homogenized [OPG study]5.7755252
GSM549100patient 110, normal, homogenized [OPG study]5.7332154
GSM549107patient 135, normal, homogenized [OPG study]5.8656556
GSM549115patient 068, normal, homogenized [OPG study]5.3338448
GSM549116patient 072, normal, homogenized [OPG study]5.5098250
GSM549120patient 078, normal, homogenized [OPG study]5.7594854
GSM549131patient 030, cancer, homogenized [OPG study]5.87757
GSM549118patient 074, normal, homogenized [OPG study]5.7121353
GSM549129patient 027, cancer, homogenized [OPG study]6.3995663
GSM549123patient 088, normal, homogenized [OPG study]5.7260554
GSM549124patient 006, cancer, homogenized [OPG study]7.2149874
GSM549126patient 015, cancer, homogenized [OPG study]6.3540163
GSM549128patient 025, cancer, homogenized [OPG study]6.1910761
GSM549103patient 117, normal, homogenized [OPG study]5.9795857
GSM549117patient 073, normal, homogenized [OPG study]5.5814852
GSM549138patient 041, cancer, homogenized [OPG study]6.3494263
GSM549141patient 045, cancer, homogenized [OPG study]6.6749867
GSM549130patient 028, cancer, homogenized [OPG study]6.0985260
GSM549101patient 111, normal, homogenized [OPG study]5.9241356
GSM549105patient 128, normal, homogenized [OPG study]5.5814851
GSM549106patient 134, normal, homogenized [OPG study]5.7101454
GSM549112patient 048, normal, homogenized [OPG study]5.6869853
GSM549125patient 011, cancer, homogenized [OPG study]6.2847362
GSM549127patient 024, cancer, homogenized [OPG study]5.9880957
GSM549135patient 035, cancer, homogenized [OPG study]6.1273260